Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting (Q43822700)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2013
edit
Language Label Description Also known as
English
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
scientific article published in October 2013

    Statements

    Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting (English)
    Daniel K Hall-Flavin
    Joel G Winner
    Josiah D Allen
    Joseph M Carhart
    Brian Proctor
    Karen A Snyder
    Maureen S Drews
    Linda L Eisterhold
    Jennifer Geske
    David A Mrazek
    1 October 2013
    535-548

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit